Cargando…
Why is salt-sensitivity of blood pressure, a known cardiovascular risk factor, not treated?
Autores principales: | Elijovich, Fernando, Laffer, Cheryl L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8193348/ https://www.ncbi.nlm.nih.gov/pubmed/34159311 http://dx.doi.org/10.1016/j.ijchy.2021.100096 |
Ejemplares similares
-
Salt-Sensitivity of Blood Pressure and Insulin Resistance
por: Ertuglu, Lale A., et al.
Publicado: (2021) -
Letter to the Editor on “Why is salt-sensitivity of blood pressure, a known cardiovascular risk factor, not treated?”
por: Diaz-Novoa, Leidy Johana, et al.
Publicado: (2021) -
A critical appraisal of the clinical effectiveness of a fixed combination of valsartan, amlodipine, and hydrochlorothiazide in achieving blood pressure goals
por: Laffer, Cheryl L, et al.
Publicado: (2011) -
The Gut Microbiome, Inflammation, and Salt-Sensitive Hypertension
por: Elijovich, Fernando, et al.
Publicado: (2020) -
Hypothesis: Unrecognized actions of ENaC blockade in improving refractory-resistant hypertension and residual cardiovascular risk
por: Elijovich, Fernando, et al.
Publicado: (2020)